All 1 tracked stories fall under one category: funding. Oncare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Sky Impact Capital
All 1 tracked stories fall under one category: funding. Oncare is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. Sky Impact Capital appears in 1 tracked Healthcare story from February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Sky Impact Capital. Shared-story counts are live from our verified record — not editorial picks.
Oncology startup Oncare has raised ₹27 crore ($3 million) in a Series A round led by Sky Impact Capital to scale its specialized clinic network. The funding will facilitate expansion from Delhi NCR into metro and Tier-2/3 cities, addressing critical gaps in accessible cancer treatment.